Sidra Medicine introduces groundbreaking sepiapterin treatment for Phenylketonuria (PKU) patients in Qatar, becoming the ...

Sidra Medicine has marked a significant medical achievement by securing regulated access to sepiapterin for patients with Phe ...

DOHA: Sidra Medicine has announced a medical achievement by facilitating access to sepiapterin for patients with ...

Lipoprotein(a), a fatty particle, can clog arteries just as surely as cholesterol but often goes undetected, striking ...

The company’s first-in-class and potential best-in-class therapeutics promise to be both effective and organ-protective and ...

In Nation Healthcare Security Administration’s (NHSA’s) announcement for the 2025 NRDL, the government’s support for ...

First oral pill for anaemia in thalassaemia patients approved by US FDA: Why is this a milestone therapy?

And just like that, 2025 has come to a close. They say one man's misfortune is another man's opportunity, but collectively, ...

Congratulations to the green sea turtle, which is off the endangered species list as of 2025 thanks to a population rebound.

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

The study was conducted by the University of East Anglia in collaboration with the Prader-Willi Syndrome Association UK, which provided funding for the research. The findings are published in the ...

Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, ...